2006
DOI: 10.1016/s0140-6736(06)69208-8
|View full text |Cite
|
Sign up to set email alerts
|

Burden of valvular heart diseases: a population-based study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

37
2,407
12
119

Year Published

2007
2007
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 4,075 publications
(2,575 citation statements)
references
References 29 publications
37
2,407
12
119
Order By: Relevance
“…Moderate or severe valvular heart disease affects ≈2.5% of the US population and increases in prevalence with age to nearly 12% of people ≥75 years old 24. With the growing elderly population, the prevalence is expected to increase further.…”
Section: Discussionmentioning
confidence: 99%
“…Moderate or severe valvular heart disease affects ≈2.5% of the US population and increases in prevalence with age to nearly 12% of people ≥75 years old 24. With the growing elderly population, the prevalence is expected to increase further.…”
Section: Discussionmentioning
confidence: 99%
“…The role of MV‐repair for functional (ischemic) MV regurgitation is still under debate2, 3 and in rheumatic disease mainly MVR is performed, as MV‐repair is more complex in these patients and less durable 4. Due to the demographic changes in Western communities and a higher incidence of MV disease in the elderly population,5 the age of patients referred for MV surgery is increasing. Although there is consensus that even in elderly patients surgical treatment should be offered,6 there remains discussion of whether MV‐repair provides the same advantages as in younger cohorts 7…”
Section: Introductionmentioning
confidence: 99%
“…Severe AS has been identified as a major cause of morbidity and mortality and, if untreated, can result in debilitating clinical symptoms, progressive heart failure, and sudden cardiac death. The economic impact of AS on the health care system is substantial 2. Traditionally, surgical aortic valve replacement (SAVR) has been the mainstay of treatment for severe AS, but has been associated with 3.2% to 5.6% perioperative mortality when performed without and with concomitant coronary artery bypass graft surgery (CABG), respectively 3, 4.…”
Section: Introductionmentioning
confidence: 99%